Immorta Bio, a scientific longevity biotechnology company focused on Treating Diseases of Aging and Treating Aging as Disease™, today announced publication of a landmark peer-reviewed study ...
Albert Einstein College of Medicine has launched the Batia and Idan Ofer program for Validation of Interventions Targeting ...
Albert Einstein College of Medicine has launched the Batia and Idan Ofer program for Validation of Interventions Targeting Aging and Longevity (BIO-VITAL), a new initiative designed to help ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is part of a new ...
News, 7 August 2025: Rejuve.Bio, the BioAI company pioneering a neural-symbolic AI‑driven co-scientist platform aimed at accelerating drug discovery for extending human healthspan and targeting ...
A protein whose expression decreases during aging could be key to preserving cellular maintenance mechanisms and preventing the progressive loss of muscle mass that occurs during aging. Scientists ...
The researchers say their findings point to a new avenue for the possible treatment of premature aging and may also be relevant to other aging-associated pathologies. Progeroid syndromes, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results